ANDA 84579, held by Barr. Hydrochlorothiazide; Reserpine.
As of Nov 16, 2026, ANDA 84579 (Reserpine And Hydrochlorothiazide), held by Barr, was first approved by FDA on Sep 30, 1975, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 30, 1975 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Reserpine And Hydrochlorothiazide50MG;0.125MG ยท tablet;oral | Hydrochlorothiazide; Reserpine | Discontinued |
| Feb 14, 1992 | Supplement 37Labeling | Approved | None posted |
| Jan 22, 1991 | Supplement 36Labeling | Approved | None posted |
| Aug 23, 1989 | Supplement 35Labeling | Approved | None posted |
| Jun 16, 1989 | Supplement 33Labeling | Approved | None posted |
| Mar 24, 1989 | Supplement 34Labeling | Approved | None posted |
| Sep 30, 1975 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters